Interstitial Cystitis
Neurology·MeSH: Cystitis, Interstitial
Prevalence
30.0 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| IW-3300 | IRONWOOD PHARMACEUTICALS INC (IRWD) |
Frequently asked questions
How many drugs are in development for Interstitial Cystitis?
BioSniper tracks 1 drug in development for Interstitial Cystitis across 1 company.
How many clinical trials target Interstitial Cystitis?
There are 2 clinical trials targeting Interstitial Cystitis tracked by BioSniper.
What is the prevalence of Interstitial Cystitis?
The estimated prevalence of Interstitial Cystitis is approximately 30.0 per 100,000 population.
Deep-dive into Interstitial Cystitis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis